Cargando…

Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma

SIMPLE SUMMARY: Hypoxia, or low oxygen levels within tumor tissue, presents a significant challenge for the management of hepatocellular carcinoma (HCC). Hypoxic microenvironments can induce changes in gene expression and cellular metabolism that promote tumor growth, metastasis, and resistance to c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huynh, Kenneth N., Rao, Sriram, Roth, Bradley, Bryan, Theodore, Fernando, Dayantha M., Dayyani, Farshid, Imagawa, David, Abi-Jaoudeh, Nadine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216171/ https://www.ncbi.nlm.nih.gov/pubmed/37345074 http://dx.doi.org/10.3390/cancers15102738

Ejemplares similares

Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma
por: Abi-Jaoudeh, Nadine, et al.
Publicado: (2021)

Changes in perfusion angiography after IVC filter placement and retrieval
por: Shreve, Lauren A., et al.
Publicado: (2022)

Endovascular management of traumatic pseudoaneurysms
por: Shreve, Lauren, et al.
Publicado: (2020)

Immunotherapy Updates in Advanced Hepatocellular Carcinoma
por: Singh, Amisha, et al.
Publicado: (2021)

Irreversible electroporation for pancreatic cancer using intraprocedural cone-beam computed tomography fusion navigation: a case report
por: Rao, Sriram, et al.
Publicado: (2021)

Drug-Eluting Embolic Loaded with Tyrosine Kinase Inhibitor Targeted Therapies for Transarterial Chemoembolization in a VX2 Model
por: Abi-Jaoudeh, Nadine, et al.
Publicado: (2023)

Optimizing the Diagnosis and Biomarker Testing for Patients with Intrahepatic Cholangiocarcinoma: A Multidisciplinary Approach
por: Cho, May T., et al.
Publicado: (2022)

Case of Brown Sequard syndrome with ipsilateral peripheral vasodilation
por: Nelson, Kari, et al.
Publicado: (2020)

Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistry
por: Wen, Pingwu, et al.
Publicado: (2022)

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
por: Tacher, Vania, et al.
Publicado: (2013)

Hypoxia-inducible factor-1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma
por: Chen, Huan, et al.
Publicado: (2022)

Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial
por: Senthil, Maheswari, et al.
Publicado: (2023)

Hypoxia inducible factors in hepatocellular carcinoma
por: Chen, Chu, et al.
Publicado: (2017)

Hypoxia-inducible factors in hepatocellular carcinoma
por: Guo, Yang, et al.
Publicado: (2020)

Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma
por: Zhang, Lin, et al.
Publicado: (2013)

HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma
por: Liu, L-p, et al.
Publicado: (2014)

Early Adoption of Checkpoint Inhibitors in Patients with Metastatic Gastric Adenocarcinoma—A Case Series of Non-Operative Long-Term Survivors
por: Kaakour, Dalia, et al.
Publicado: (2022)

Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma
por: Zhu, Andrew X., et al.
Publicado: (2022)

SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors-1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets
por: Cannito, Stefania, et al.
Publicado: (2019)

HSP90α Mediates Sorafenib Resistance in Human Hepatocellular Carcinoma by Necroptosis Inhibition under Hypoxia
por: Liao, Yan, et al.
Publicado: (2021)

Expression of caspase-3 and hypoxia inducible factor 1α in hepatocellular carcinoma complicated by hemorrhage and necrosis
por: Liang, Hui, et al.
Publicado: (2021)

Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC)
por: Duffy, Austin, et al.
Publicado: (2014)

ASO Author Reflections: Challenges of Circulating Tumor DNA in the Management of Gastrointestinal Peritoneal Carcinomatosis
por: Sullivan, Brittany G., et al.
Publicado: (2022)

Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis
por: Méndez-Blanco, Carolina, et al.
Publicado: (2021)

Expression Characteristics of Hypoxia-Inducible Factor-1α and Its Clinical Values in Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Li, Shanshan, et al.
Publicado: (2011)

Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma
por: Zhou, Xinke, et al.
Publicado: (2015)

Lack of MOF Decreases Susceptibility to Hypoxia and Promotes Multidrug Resistance in Hepatocellular Carcinoma via HIF-1α
por: Wang, Meng, et al.
Publicado: (2021)

Clinically Meaningful Use of Blood Tumor Markers in Oncology
por: Holdenrieder, Stefan, et al.
Publicado: (2016)

Durable Response after Repeat Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Patient with Extensive Mucinous Adenocarcinoma of the Appendix
por: Kaakour, Dalia, et al.
Publicado: (2023)

Partial Reversal of Anosmia Following Platinum-Based Chemotherapy in a Patient With Colorectal Adenocarcinoma
por: Mahadevan, Aditya, et al.
Publicado: (2023)

Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis
por: Kim, Jin-Wook
Publicado: (2010)

The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
por: Luo, Dongjun, et al.
Publicado: (2014)

Medullary carcinoma of the duodenum treated with pembrolizumab: a case report
por: Liu, Louisa, et al.
Publicado: (2023)

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)
por: Dayyani, Farshid, et al.
Publicado: (2010)

Upregulation of hypoxia-inducible factor 1α mRNA expression was associated with poor prognosis in patients with hepatocellular carcinoma
por: Cheng, Wei, et al.
Publicado: (2019)

14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1α
por: Tang, Yufu, et al.
Publicado: (2016)

Co-expression of KIAA1199 and hypoxia-inducible factor 1α is a biomarker for an unfavorable prognosis in hepatocellular carcinoma
por: Wang, Dan, et al.
Publicado: (2020)

Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
por: Zeng, Zhi, et al.
Publicado: (2021)

Chronic Intermittent Hypoxia Increases Cell Proliferation in Hepatocellular Carcinoma
por: Carreres, Lydie, et al.
Publicado: (2022)

Dishevelled Associated Activator Of Morphogenesis (DAAM) Facilitates Invasion of Hepatocellular Carcinoma by Upregulating Hypoxia-Inducible Factor 1α (HIF-1α) Expression
por: Fang, Xiaoxu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bim2fmm6l4t3fcft98suvfu1nq